Sfoglia per Autore
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia
2018 Calza, Leonardo*; Colangeli, Vincenzo; Borderi, Marco; Manfredi, Roberto; Marconi, Lorenzo; Bon, Isabella; Re, Maria Carla; Viale, Pierluigi
Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study.
2019 Calza L, di Pietro G, Colangeli V, Borderi, Zaghi I, Malosso P, Bon I, Re MC, Viale P
Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy
2019 Calza L.; Sachs M.; Colangeli V.; Borderi M.; Granozzi B.; Malosso P.; Comai G.; Corradetti V.; La Manna G.; Viale P.
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients
2019 Calza, Leonardo; Colangeli, Vincenzo; Borderi, Marco; Coladonato, Simona; Tazza, Beatrice; Bon, Isabella; Re, Maria Carla; Viale, Pierluigi
Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease.
2019 Calza L, Colangeli V, Borderi M, Coladonato S, Tazza B, Fornaro G, Badia L, Guardigni V, Verucchi G, Viale P.
No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-up
2020 Calza L, Borderi M, Colangeli V, Borioni A, Coladonato S, Granozzi B, Viale P
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir
2020 Calza L.; Colangeli V.; Borderi M.; Bon I.; Borioni A.; Volpato F.; Re M.C.; Viale P.
Prevalence of transmitted drug resistance mutations among newly diagnosed HIV-1-infected patients in a large teaching hospital of the Northern Italy
2020 Calza L, Tamburello M, Borderi M, Colangeli V, Testi D, Amedeo A, Re MC, Bon I
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy
2021 Calza L.; Bon I.; Tadolini M.; Borderi M.; Colangeli V.; Badia L.; Verucchi G.; Rossini G.; Vocale C.; Gaibani P.; Viale P.; Attard L.
Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir
2022 Calza L, Borderi M, Colangeli V, Miani T, Nuti B, Bon I, Lazzarotto T, Viale P
Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience.
2023 Calza L, Colangeli V, Pensalfine G, Appolloni L, Vitale S, Bon I, Viale P
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile